Rhumbline Advisers decreased its position in shares of Envista Holdings Co. (NYSE:NVST – Get Rating) by 0.9% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 423,369 shares of the company's stock after selling 3,942 shares during the period. Rhumbline Advisers owned approximately 0.26% of Envista worth $20,622,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. EFG Asset Management North America Corp. bought a new position in Envista during the first quarter valued at $2,257,000. Principal Financial Group Inc. increased its position in Envista by 140.5% during the first quarter. Principal Financial Group Inc. now owns 1,318,947 shares of the company's stock valued at $64,247,000 after acquiring an additional 770,581 shares during the last quarter. Eversept Partners LP increased its position in Envista by 4.7% during the fourth quarter. Eversept Partners LP now owns 849,298 shares of the company's stock valued at $38,269,000 after acquiring an additional 38,417 shares during the last quarter. Champlain Investment Partners LLC increased its position in Envista by 0.5% during the fourth quarter. Champlain Investment Partners LLC now owns 813,855 shares of the company's stock valued at $36,672,000 after acquiring an additional 3,810 shares during the last quarter. Finally, Buckley Wealth Management LLC bought a new position in Envista during the first quarter valued at $324,000.

Envista Stock Performance

NVST stock opened at $36.60 on Thursday. Envista Holdings Co. has a one year low of $34.75 and a one year high of $52.03. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 1.11. The firm has a market cap of $5.98 billion, a price-to-earnings ratio of 21.79, a PEG ratio of 1.42 and a beta of 1.54. The firm has a 50-day simple moving average of $38.88 and a two-hundred day simple moving average of $42.19.

Wall Street Analyst Weigh In

Envista Company Profile

(Get Rating)

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.

Featured Stories

• Get a free copy of the StockNews.com research report on Envista (NVST)
• 3 High Margin Chipmakers Bound to Recover
• 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
• REV Group Has A Deep Moat In The World Of EVs
• Is G-III Apparel Group, Ltd. A Value Trap?
• Bank Of America Sees Upside In These 2 European Alcohol Stocks

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.